Updated hourlyHourly refreshSun, Nov 1, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Travel
Little Rock, Arkansas--(October 14, 2026) - Inuvo (NYSE American: INUV) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Inuvo is scheduled to present on Tuesday, October 20, 2026 at 9:00 AM PT. CEO Rob Buchner, CFO Derric Ciccone, and CAO Aleesha Parris will represent the company. Presentation DetailsEvent: LD Micro Main...
Oct 14 · 12:15·Newsfile
Finance
Kaplan Fox announces a securities class action against Beta Bionics (NASDAQ: BBNX) for investors from July 30, 2025 to Feb. 24, 2026.
Oct 14 · 12:15·GlobeNewswire
Finance · SaaS
MONTEVIDEO, Uruguay, Oct. 14, 2026 -- DLocal Limited (NASDAQ: DLO, “dLocal” or the “Company”), the leading cross-border payment platform connecting global merchants to emerging markets, intends to release financial results for its third fiscal quarter ended September 30, 2026 on November 12, 2026 after market close.
Oct 14 · 12:15·GlobeNewswire
Finance
LOS ANGELES, Oct. 14, 2026 -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Papa John's International, Inc. ("Papa John's" or "the Company") (NASDAQ: PZZA) for violations of §§10(b) and...
Oct 14 · 12:06·PR Newswire
Finance
Genpact's latest finance and accounting (F&A) Agentic Solution helps reduce past due receivables and increase touchless cash applications NEW YORK, Oct. 14, 2026 -- Genpact (NYSE: G), the Agentic Operations company, today announced the general availability of the Genpact...
Oct 14 · 12:05·PR Newswire
Finance · Biotech & pharma
PHILADELPHIA, Oct. 14, 2026 -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the company will attend the upcoming 2026 Jefferies Global Healthcare Conference in London on November 18, 2026.
Oct 14 · 12:05·GlobeNewswire
Finance
MENLO PARK, Calif., Oct. 14, 2026 -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for the third quarter ended September 30, 2026 after the market close on Wednesday, November 4, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.
Oct 14 · 12:05·GlobeNewswire
Finance
MaxCyte will host its third quarter 2026 earnings conference call on November 10, 2026
MaxCyte will host its third quarter 2026 earnings conference call on November 10, 2026
Oct 14 · 12:05·GlobeNewswire
Finance · Logistics
TAMPERE, Finland, Oct. 14, 2026 -- Twin Disc, Inc. (NASDAQ: TWIN) subsidiary Katsa today announced that it is expanding its capacity with a 54,000-square-foot gearbox assembly facility and warehouse in Pirkkala, Finland in response to a double-digit percentage year-over-year increase in demand.
Oct 14 · 12:00·GlobeNewswire
Finance
BEDMINSTER, N.J., Oct. 14, 2026 -- Freshpet, Inc. (Nasdaq: FRPT) (“Freshpet” or the “Company”) today announced it will report results for the third quarter ended September 30, 2026 on Wednesday, November 4, 2026 before market open.
Oct 14 · 12:00·GlobeNewswire
Finance
Stronger-than-anticipated preorder demand, ThermoWorks has fulfilled its preorder backlog and is now shipping its first precision kitchen scale directly from inventory.
Stronger-than-anticipated preorder demand, ThermoWorks has fulfilled its preorder backlog and is now shipping its first precision kitchen scale directly from inventory.
Oct 14 · 12:00·GlobeNewswire
Finance · Healthcare
WATERTOWN, Mass., Oct. 14, 2026 -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that the company will participate in a panel during Chardan’s 10th Annual Healthcare Conference on October 20, 2026. Details below:
Oct 14 · 12:00·GlobeNewswire